nach oben

Journal of Nephrology

Erschienen in:

06.12.2022 | Original Article

The spectrum and changes of biopsy-proven kidney diseases in Chinese children

verfasst von: Guohua He, Liyuan Tao, Chenglong Li, Xuhui Zhong, Haibo Wang, Jie Ding

Erschienen in: Journal of Nephrology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

The study aimed to investigate the spectrum of biopsy-proven kidney disease in Chinese children.

Methods

Records of children 0–17 years old who underwent native kidney biopsy from June 1st, 2013 to December 31st, 2018 in the national inpatients' database of China were analyzed. Biopsy-proven kidney diseases of different sex, age groups, and diagnosis, and the changing patterns of kidney disease compared with the previous study were analyzed.

Results

A total of 21,311 patients from 232 hospitals with a median age of 11.34 years were included. Immunoglobulin A vasculitis with nephritis (IgAVN) was the most common pathological finding [29.17%, 95% confidence interval (confidence interval, CI) = 28.56–29.78], followed by IgA nephropathy (IgAN) (22.70%, 95% CI = 22.14–23.27).

IgAN was the most common finding in patients with hematuria (60.75%, 95% CI = 58.83–62.65], proteinuria (33.43%, 95% CI = 30.54–36.42), and hematuria plus proteinuria (62.77%, 95% CI = 56.19–69.02). Minimal change disease was the most common finding (40.69%, 95% CI = 39.41–41.98) in nephrotic syndrome.

The proportion of IgAVN in patients with biopsy-proven glomerular disease increased year by year during 2013–2018 (p for trend < 0.001) and was higher than that of 2004–2014 [29.41% (95% CI = 29.10–29.72) in 2013–2018 vs. 13.35% (95% CI = 12.97–13.73) 2004–2014, p < 0.001]. The proportion of hepatitis B virus associated nephritis during 2013–2018 was lower than that of 2004–2014 [0.44% (95% CI = 0.36–0.54) in 2013–2018 vs. 0.87% (95% CI = 0.67–1.10) in 2004–2014, p < 0.001].

Conclusions

IgAVN and IgAN were the most common types of pathological findings in children who underwent kidney biopsies from 2013 to 2018. The pathological spectrum of kidney biopsy changed over time.

Nur mit Berechtigung zugänglich

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272. https://doi.org/10.1016/S0140-6736(13)60687-XCrossRefPubMed

Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379:165–180. https://doi.org/10.1016/s0140-6736(11)60178-5CrossRefPubMed

Calderon-Margalit R, Golan E, Twig G, Leiba A, Tzur D, Afek A, Skorecki K, Vivante A (2018) History of childhood kidney disease and risk of adult end-stage renal disease. N Engl J Med 378:428–438. https://doi.org/10.1056/NEJMoa1700993CrossRefPubMed

Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu Z-H, Mejía-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders J-SF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Floege J (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1–S276. https://doi.org/10.1016/j.kint.2021.05.021CrossRef

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int, Suppl 3:1–150

Hogan JJ, Mocanu M, Berns JS (2016) The native kidney biopsy: update and evidence for best practice. Clin J Am Soc Nephrol 11:354–362. https://doi.org/10.2215/cjn.05750515CrossRefPubMed

Souilmi FZ, Houssaini TS, Alaoui H, Harmouch T, Atmani S, Hida M (2015) Indications and results of renal biopsy in children: a single-center experience from Morocco. Saudi J Kidney Dis Transpl 26:810–815. https://doi.org/10.4103/1319-2442.160225CrossRefPubMed

Alhasan K, Aloudah NM, Bakhit AA, Alhamad YM, Chihabeddine KM, Alfaadhel TA, Aljohani TE, Alhozali HM, Alsuwaida AO (2020) Renal histopathology spectrum in children with kidney diseases in Saudi Arabia, 1998–2017. Saudi Med J 41:369–375CrossRefPubMedCentralPubMed

Imtiaz S, Nasir K, Drohlia MF, Salman B, Ahmad A (2016) Frequency of kidney diseases and clinical indications of pediatric renal biopsy: a single center experience. Indian J Nephrol 26:199–205. https://doi.org/10.4103/0971-4065.159304CrossRefPubMedCentralPubMed

10.

Paripović D, Kostić M, Kruščić D, Spasojević B, Lomić G, Marković-Lipkovski J, Basta-Jovanović G, Smoljanić Ž, Peco-Antić A (2012) Indications and results of renal biopsy in children: a 10-year review from a single center in Serbia. J Nephrol 25:1054–1059. https://doi.org/10.5301/jn.5000095CrossRefPubMed

11.

Muthu V, Ramachandran R, Nada R, Kumar V, Rathi M, Kohli HS, Jha V, Gupta KL, Sakhuja V (2018) Clinicopathological spectrum of glomerular diseases in adolescents: a single-center experience over 4 years. Indian J Nephrol 28:15–20. https://doi.org/10.4103/ijn.IJN_239_16CrossRefPubMedCentralPubMed

12.

Arapović A, Vukojević K, Filipović N, Glavina Durdov M, Ljubanović-Galešić D, Saraga-Babić M, Prgomet S, Simičić Majce A, Belavić A, Borić Škaro D, Ljutić D, Saraga M (2020) Epidemiology of 10-year paediatric renal biopsies in the region of southern Croatia. BMC Nephrol 21:65. https://doi.org/10.1186/s12882-020-01727-7CrossRefPubMedCentralPubMed

13.

Nie S, He W, Huang T, Liu D, Wang G, Geng J, Chen N, Xu G, Zhang P, Luo Y, Nie J, Xu X, Hou FF (2018) The spectrum of biopsy-proven glomerular diseases among children in China: a national, cross-sectional survey. Clin J Am Soc Nephrol 13:1047–1054. https://doi.org/10.2215/cjn.11461017CrossRefPubMedCentralPubMed

14.

Yin XL, Zou MS, Zhang Y, Wang J, Liu TL, Tang JH, Qiu LR, Chen Y, Yuan HQ, Zhou JH (2013) Twenty-three-year review of disease patterns from renal biopsies: an experience from a pediatric renal center. J Nephrol 26:699–707. https://doi.org/10.5301/jn.5000267CrossRefPubMed

15.

Jiang M, Xiao Z, Rong L, Xu Y, Chen L, Mo Y, Sun L, Sun W, Jiang X (2016) Twenty-eight-year review of childhood renal diseases from renal biopsy data: a single centre in China. Nephrology (Carlton) 21:1003–1009. https://doi.org/10.1111/nep.12702CrossRefPubMed

16.

Wang N, Zhu T, Tao Y (2018) Clinicopathological features of pediatric renal biopsies in the plateau regions of China. J Int Med Res 46:4539–4546. https://doi.org/10.1177/0300060518786908CrossRefPubMedCentralPubMed

17.

He G, Li C, Wang S, Wang H, Ding J (2022) Association of insurance status with chronic kidney disease stage at diagnosis in children. Pediatr Nephrol. https://doi.org/10.1007/s00467-022-05493-6CrossRefPubMed

18.

Shi X, Shi Y, Zhang L, Gan L, Zhong X, Huang Y, Yao C, Wang Y, Dong C, Liu B, Wang F, Wang H, Ding J (2021) Analysis of chronic kidney disease among national hospitalization data with 14 million children. BMC Nephrol 22:195. https://doi.org/10.1186/s12882-021-02383-1CrossRefPubMedCentralPubMed

19.

He G, Li C, Zhong X, Wang F, Wang H, Shi Y, Gan L, Ding J (2021) Risk factors for progression of chronic kidney disease with glomerular etiology in hospitalized children. Front Pediatr 9:752717. https://doi.org/10.3389/fped.2021.752717CrossRefPubMedCentralPubMed

20.

Zhang L, Zhao M, Zuo L, Wang Y, Yu F, Zhang H, Wang H, Group C-NW (2020) China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl 10:e97–e185. https://doi.org/10.1016/j.kisu.2020.09.001CrossRef

21.

Yang C, Gao B, Zhao X, Su Z, Sun X, Wang HY, Zhang P, Wang R, Liu J, Tang W, Zhang D, Chu H, Wang J, Wang F, Wang S, Zuo L, Wang Y, Yu F, Wang H, Zhang L, Zhang H, Yang L, Chen J, Zhao MH (2020) Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int 98:1419–1423. https://doi.org/10.1016/j.kint.2020.09.003CrossRefPubMed

22.

Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H, Wang H (2011) Group C-NW (2019) China Kidney Disease Network (CK-NET) 2015 Annual Data Report. Kidney Int Suppl 9:e1–e81. https://doi.org/10.1016/j.kisu.2018.11.001CrossRef

23.

Wang F, Yang C, Long J, Zhao X, Tang W, Zhang D, Bai K, Su Z, Gao B, Chu H, Wang J, Sun X, Wang S, Zuo L, Wang Y, Yu F, Wang H, Zhang L, Zhao MH (2019) Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET). Kidney Int 95:501–505. https://doi.org/10.1016/j.kint.2018.11.011CrossRefPubMed

24.

Huang YM, Xu D, Long J, Shi Y, Zhang L, Wang H, Levin A, Zhao MH (2019) Spectrum of chronic kidney disease in China: a national study based on hospitalized patients from 2010 to 2015. Nephrology (Carlton) 24:725–736. https://doi.org/10.1111/nep.13489CrossRefPubMed

25.

Li J, Cui Z, Long J, Huang W, Wang J, Zhang H, Wang H, Zhang L, Ronco P, Zhao MH (2018) Primary glomerular nephropathy among hospitalized patients in a national database in China. Nephrol Dial Transplant 33:2173–2181. https://doi.org/10.1093/ndt/gfy022CrossRefPubMed

26.

Lin Y, Yang C, Chu H, Wu J, Lin K, Shi Y, Wang H, Kong G, Zhang L (2019) Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis. BMC Nephrol 20:363. https://doi.org/10.1186/s12882-019-1538-0CrossRefPubMedCentralPubMed

27.

Gu J, Shi Y, Chen N, Wang H, Chen T (2020) Ambient fine particulate matter and hospital admissions for ischemic and hemorrhagic strokes and transient ischemic attack in 248 Chinese cities. Sci Total Environ 715:136896. https://doi.org/10.1016/j.scitotenv.2020.136896CrossRefPubMed

28.

Jiang YZ, Shi Y, Shi Y, Gan LX, Kong YY, Zhu ZJ, Wang HB, Sun LY (2019) Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report. Orphanet J Rare Dis 14:292. https://doi.org/10.1186/s13023-019-1268-1CrossRefPubMedCentralPubMed

29.

Lu L, Xiong W, Yang X, Ma X, Wang C, Yan B, Zhang Q, Mu J, Zhang Y, Gao H, Liu W, Zhang L, Li Z, Sander JW, Wang Y, Zhou D (2020) In-hospital mortality of status epilepticus in China: Results from a nationwide survey. Seizure 75:96–100. https://doi.org/10.1016/j.seizure.2019.11.006CrossRefPubMed

30.

Zeng C, Lane NE, Englund M, Xie D, Chen H, Zhang Y, Wang H, Lei G (2019) In-hospital mortality after hip arthroplasty in China: analysis of a large national database. Bone Joint J 101-B:1209–1217CrossRefPubMed

31.

Shen L, Wang S, Chen W, Fu Q, Evans R, Lan F, Li W, Xu J, Zhang Z (2019) Understanding the function constitution and influence factors on communication for the WeChat official account of top tertiary hospitals in China: cross-sectional study. J Med Internet Res 21:e13025. https://doi.org/10.2196/13025CrossRefPubMedCentralPubMed

32.

Modi ZJ, Waldo A, Selewski DT, Troost JP, Gipson DS (2021) Inpatient pediatric CKD health care utilization and mortality in the United States. Am J Kidney Dis 77:500–508. https://doi.org/10.1053/j.ajkd.2020.07.024CrossRefPubMed

33.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung J-T, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine C-E, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O’Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V (2019) US renal data system 2018 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 73:A7–A8. https://doi.org/10.1053/j.ajkd.2019.01.001CrossRefPubMedCentralPubMed

34.

Madani A, Fahimi D, Esfehani ST, Mohsseni P, Atayee N, Ahmadi M, Elmi F, Haddadi M (2003) Glomerular diseases in Iranian children: clinico-pathological correlations. Pediatr Nephrol 18:925–928. https://doi.org/10.1007/s00467-003-1166-5CrossRefPubMed

35.

(2009) Evidence-based guidelines on diagnosis and treatment of childhood common renal diseases (II): evidence-based guideline on diagnosis and treatment of Henoch-Schonlein purpura nephritis. Zhonghua Er Ke Za Zhi 47:911–913

36.

(2009) Evidence-based guidelines on diagnosis and treatment of childhood common renal diseases. (I) Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing/steroid-dependent nephrotic syndrome (for trial implementation). Zhonghua Er Ke Za Zhi 47:167–170

37.

Rheault MN, Wenderfer SE (2018) Evolving Epidemiology of Pediatric Glomerular Disease. Clin J Am Soc Nephrol 13:977–978. https://doi.org/10.2215/cjn.06220518CrossRefPubMedCentralPubMed

38.

Hussain F, Mallik M, Marks SD, Watson AR (2010) Renal biopsies in children: current practice and audit of outcomes. Nephrol Dial Transplant 25:485–489. https://doi.org/10.1093/ndt/gfp434CrossRefPubMed

39.

Coppo R, Gianoglio B, Porcellini MG, Maringhini S (1998) Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant 13:293–297. https://doi.org/10.1093/oxfordjournals.ndt.a027821CrossRefPubMed

40.

Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC, Mezzano SA, Floege J, Nachman PH, Gipson DS, Praga M (2012) Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274

41.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557. https://doi.org/10.1016/j.vaccine.2009.08.048CrossRefPubMed

Titel: The spectrum and changes of biopsy-proven kidney diseases in Chinese children
verfasst von: Guohua He
Liyuan Tao
Chenglong Li
Xuhui Zhong
Haibo Wang
Jie Ding
Publikationsdatum: 06.12.2022
Verlag: Springer International Publishing
Erschienen in: Journal of Nephrology / Ausgabe 2/2023
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-022-01527-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Aim

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature

Specific attention deficits in patients with end stage kidney disease

Citric acid-based bicarbonate dialysate attenuates aortic arch calcification in maintenance hemodialysis patients: a retrospective observational study

Correction to: Semiquantitative classification (SQC) and Oxford classifications predict poor renal outcome better than The International Study of Kidney Disease in Children (ISKDC) and Haas in patients with IgAV nephritis: a multicenter study

Genetic diagnosis and treatment of hereditary renal tubular disease with hypokalemia and alkalosis